NUS Competitors

Stocks . USA . 
Stock . Nu Skin Enterprises
NUS Stock  USD 10.10  0.60  5.61%   
Nu Skin Enterprises competes with Helen Of, Beyond Meat, MGP Ingredients, Village Super, and Above Food; as well as few others. The company runs under Personal Care Products sector within Consumer Staples industry. Analyzing Nu Skin competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Nu Skin to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Nu Skin Correlation with its peers.

Nu Skin vs QuantaSing Group Correlation

Very good diversification

The correlation between Nu Skin Enterprises and QSG is -0.28 (i.e., Very good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Nu Skin Enterprises and QSG in the same portfolio, assuming nothing else is changed.

Moving against NUS Stock

  0.66T ATT Inc Earnings Call This WeekPairCorr
  0.51BRK-A Berkshire HathawayPairCorr
  0.45TRV The Travelers CompaniesPairCorr
  0.42VZ Verizon Communications Earnings Call TodayPairCorr
  0.4MSFT MicrosoftPairCorr
Specify up to 10 symbols:
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Nu Skin's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
6.8710.1013.33
Details
Intrinsic
Valuation
LowRealHigh
6.9710.2013.43
Details
Naive
Forecast
LowNextHigh
6.589.8113.04
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
9.2710.4411.60
Details

Nu Skin Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Nu Skin and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of NUS and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Nu Skin Enterprises does not affect the price movement of the other competitor.

High positive correlations

LINC
+ 0.96
APEI
OTLY
+ 0.72
ABVE
ABVE
+ 0.67
BYND
OTLY
+ 0.67
BYND
LINC
+ 0.51
VLGEA
APEI
+ 0.47
VLGEA
  

High negative correlations

OTLY
- 0.78
LINC
OTLY
- 0.75
APEI
OTLY
- 0.7
VLGEA
APEI
- 0.63
BYND
LINC
- 0.61
BYND
LINC
- 0.57
ABVE

Risk-Adjusted Indicators

There is a big difference between NUS Stock performing well and Nu Skin Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Nu Skin's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
HELE  2.20 (0.20) 0.00 (3.26) 0.00 
 0.00 
 4.33 
(4.37)
 13.25 
BYND  4.93 (0.68) 0.00  3.82  0.00 
 0.00 
 11.83 
(8.96)
 45.83 
MGPI  1.68 (0.01) 0.00  0.04  2.12 
(1.79)
 3.43 
(4.14)
 12.18 
VLGEA  1.16  0.16  0.07 (1.94) 1.18 
(1.26)
 2.82 
(2.01)
 7.68 
ABVE  7.43 (0.47) 0.00 (0.19) 0.00 
 0.00 
 14.07 
(15.33)
 52.76 
VSTA  0.94 (0.01)(0.03) 0.01  1.50 
(1.14)
 1.42 
(1.61)
 11.44 
APEI  1.65  0.45  0.23  2.87  1.39 
(1.98)
 5.11 
(2.73)
 10.54 
LINC  2.06  0.64  0.21 (2.08) 1.96 
(2.17)
 5.32 
(3.40)
 20.71 
OTLY  2.44 (0.35) 0.00  1.30  0.00 
 0.00 
 4.77 
(5.57)
 16.31 
QSG  2.66 (0.70) 0.00 (2.24) 0.00 
 0.00 
 6.26 
(6.49)
 15.16 

Nu Skin Competitive Analysis

The better you understand Nu Skin competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Nu Skin's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Nu Skin's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
NUS HELE BYND MGPI VLGEA ABVE VSTA APEI LINC OTLY
 5.61 
 10.10 
NUS
 3.52 
 16.70 
Helen
 6.02 
 0.78 
Beyond
 1.85 
 24.44 
MGP
 2.09 
 34.68 
Village
 11.76 
 1.95 
Above
 1.61 
 4.90 
Vasta
 1.95 
 42.27 
American
 0.23 
 26.67 
Lincoln
 4.31 
 11.61 
Oatly
Market Volatility
(90 Days Market Risk)
Somewhat reliable
Not too volatile
Out of control
Not too volatile
Very steady
Extremely Dangerous
Somewhat reliable
Very steady
Not too volatile
Somewhat reliable
Market Performance
(90 Days Performance)
Weakest
Weakest
Weakest
Weak
Fair
Weakest
Weakest
Solid
Solid
Weakest
Odds of Financial Distress
(Probability Of Bankruptcy)
Low
Small
Strong
Small
Low
High
Low
Low
Low
Risky
Current Valuation
(Equity Enterprise Value)
Fairly Valued
Under Valued
Over Valued
Over Valued
Over Valued
Fairly Valued
Fairly Valued
Under Valued
Over Valued
Over Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Cautious Hold
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Strong Sell
Cautious Hold
Strong Buy
Cautious Hold
Strong Sell
Current Ratio
2.3
2.12
7.68
4.53
1.5
N/A
1.5
2.43
1.92
1.94
Net Asset
1.47 B
3.13 B
678.15 M
1.41 B
1 B
143.89 M
7.21 B
570.1 M
436.56 M
803.98 M
Profit Margin
0.0702
-0.44
-0.82
-0.0262
0.0237
-0.23
0.28
0.0488
0.0286
-0.27
EBITDA
(78.83 M)
268.61 M
(125.5 M)
98.87 M
110.23 M
(38.25 M)
606.8 M
52.37 M
28.61 M
(86.13 M)
Operating Margin
0.0594
0.11
-0.47
0.18
0.0259
-0.23
-0.16
0.0842
0.0445
-0.0551
Current Valuation
530.8 M
1.32 B
1.59 B
787.41 M
715.79 M
197.74 M
550.08 M
724.7 M
1.01 B
826.21 M
Price To Book
0.62
0.47
59.32
0.61
1.0
N/A
0.42
2.68
4.47
18.06
Retained Earnings
1.71 B
1.31 B
(1.24 B)
563.93 M
423.69 M
(103.88 M)
154.93 M
(41.8 M)
79.17 M
(1.25 B)
Current Asset
706.39 M
755.09 M
72.16 M
91.18 M
159.83 M
N/A
1.89 M
131.11 M
105.09 M
N/A
Five Year Return
3.09
N/A
N/A
0.67
4.1
N/A
N/A
N/A
N/A
N/A
Beta
0.99
0.78
2.55
0.36
0.52
-0.063
-0.27
1.72
0.99
1.97
Number Of Employees
3.1 K
1.88 K
754
660
2.16 K
4
1.57 K
2.49 K
1.88 K
1.39 K
Shares Outstanding
48.75 M
23.07 M
453.57 M
21.29 M
10.63 M
51.19 M
15.97 M
18.09 M
31.62 M
30.33 M
Cash Flow From Operations
111.74 M
113.21 M
(98.81 M)
102.28 M
93.22 M
7.15 M
175.44 M
48.87 M
29.31 M
(114.43 M)
Annual Yield
0.0245
N/A
N/A
0.0191
0.0288
N/A
N/A
N/A
N/A
N/A
Total Debt
478.23 M
956.84 M
1.22 B
339.64 M
340.55 M
117.51 M
1.18 B
200.62 M
177.56 M
491.45 M
Return On Equity
0.15
-0.64
-11.67
-0.0172
0.12
N/A
0.11
0.11
0.0794
-1.79
Return On Asset
0.0412
0.0344
-0.15
0.0487
0.0455
-0.16
0.0162
0.0663
0.0348
-0.0576
Number Of Shares Shorted
2.31 M
2.24 M
136.99 M
1.35 M
173.15 K
872.88 K
6.33 K
1.7 M
1.05 M
436.08 K
Book Value Per Share
16.29
36.98
-10.22
40.16
33.96
-0.44
61.28
15.45
5.88
0.62
Current Liabilities
407.6 M
267.6 M
17.2 M
37.66 M
99.3 M
N/A
2.1 M
50.8 M
71.45 M
N/A
Total Asset
1.47 B
3.13 B
678.15 M
1.41 B
1 B
143.89 M
7.21 B
570.1 M
436.56 M
803.98 M
Debt To Equity
0.59
0.87
N/A
0.35
1.08
N/A
0.24
0.87
0.72
0.15
Short Ratio
5.59
2.04
2.23
3.34
4.12
0.57
1.67
6.79
4.47
6.29
Target Price
7.5
28.0
1.61
34.8
N/A
N/A
4.59
43.33
28.2
19.33
Last Dividend Paid
0.24
N/A
N/A
0.48
0.75
N/A
N/A
N/A
N/A
N/A
Shares Owned By Institutions
78.25
98.63
24.91
61.75
64.12
12.96
22.66
95.19
84.43
56.46
Market Capitalization
476.78 M
385.3 M
352.02 M
534.7 M
511.65 M
99.82 M
398.41 M
764.45 M
841.51 M
337.54 M
Price To Earning
10.7
9.53
-253.14
53.02
11.33
N/A
N/A
10.53
4.61
N/A
Price To Earnings To Growth
2.35
0.97
40.75
1.13
N/A
N/A
39.96
1.23
1.99
-0.13
Price To Sales
0.33
0.21
1.21
0.92
0.22
0.34
0.23
1.17
1.7
0.4
Net Income
(146.59 M)
123.75 M
(160.28 M)
34.47 M
56.38 M
(53.31 M)
486.49 M
16.11 M
9.89 M
(202.27 M)
Earnings Per Share
2.19
-34.48
-3.17
-0.63
3.76
-1.78
1.14
1.31
0.45
-7.4
Shares Owned By Insiders
2.19
1.37
11.23
32.03
13.55
16.0
50.34
4.82
7.28
9.44
Revenue
1.73 B
1.91 B
326.45 M
703.62 M
2.32 B
368.42 M
1.67 B
624.56 M
440.06 M
823.67 M
Working Capital
241.99 M
465.45 M
225 M
453.69 M
25.48 M
(85.41 M)
222.15 M
181.42 M
21.04 M
(235.93 M)
Cash And Equivalents
186.88 M
40.92 M
390.18 M
37.41 M
134.83 M
N/A
565.53 M
157.72 M
66.98 M
275.1 M
Cash Per Share
7.69
1.71
6.12
1.7
9.29
N/A
6.86
8.35
2.5
0.47
Gross Profit
1.09 B
841.96 M
28.82 M
225.62 M
666.04 M
(8.13 M)
1.06 B
354.92 M
298.14 M
257.92 M
Day Typical Price
10.28
16.92
0.8
24.61
34.64
2.03
4.89
41.77
26.23
11.46
Accumulation Distribution
0.0689
0.0481
0.0833
0.0323
0.0371
0.15
0.0673
0.0546
0.055
0.0671
Market Facilitation Index
0.74
0.84
0.07
0.81
1.31
0.34
0.34
2.33
1.47
0.79
Daily Balance Of Power
(0.81)
(0.73)
(0.71)
(0.57)
0.542
(0.76)
(0.24)
0.3476
0.0408
0.6076
Period Momentum Indicator
(0.60)
(0.61)
(0.05)
(0.46)
0.71
(0.26)
(0.08)
0.81
0.06
0.48
Rate Of Daily Change
0.94
0.96
0.94
0.98
1.02
0.88
0.98
1.02
1.0
1.04
Day Median Price
10.37
17.03
0.81
24.7
34.63
2.07
4.88
41.52
26.01
11.39
Price Action Indicator
(0.57)
(0.63)
(0.05)
(0.48)
0.41
(0.25)
(0.02)
1.16
0.7
0.46
Relative Strength Index
45.43
36.53
37.72
49.35
50.8
44.78
49.07
63.03
62.83
47.08
Coefficient Of Variation
(9,670)
(1,516)
(1,116)
4248.57
922.06
(2,942)
14858.7
478.53
467.68
(910.50)
Mean Deviation
2.04
2.2
4.93
1.68
1.16
7.43
0.9396
1.65
2.06
2.44
Jensen Alpha
(0.1)
(0.20)
(0.68)
(0.01)
0.1584
(0.47)
(0.01)
0.4474
0.6423
(0.35)
Total Risk Alpha
(0.27)
(0.40)
(1.23)
(0.12)
0.0473
(1.12)
(0.12)
0.2981
0.4164
(0.59)
Sortino Ratio
N/A
N/A
N/A
(0)
0.072
N/A
(0.03)
0.2279
0.2092
N/A
Downside Variance
N/A
N/A
N/A
5.22
2.05
N/A
3.08
3.15
7.57
N/A
Standard Deviation
3.23
2.83
7.63
2.3
1.52
10.6
1.78
2.23
2.98
3.19
Kurtosis
9.17
0.0991
9.3
2.15
0.215
2.99
13.25
0.6637
4.47
0.562
Potential Upside
4.85
4.33
11.83
3.43
2.82
14.07
1.42
5.11
5.32
4.77
Treynor Ratio
(0.04)
(3.26)
3.82
0.0414
(1.94)
(0.19)
0.0077
2.87
(2.08)
1.3
Maximum Drawdown
20.63
13.25
45.83
12.18
7.68
52.76
11.44
10.54
20.71
16.31
Variance
10.44
8.01
58.2
5.31
2.3
112.34
3.15
4.96
8.87
10.2
Market Risk Adjusted Performance
(0.03)
(3.25)
3.83
0.0514
(1.93)
(0.18)
0.0177
2.88
(2.07)
1.31
Risk Adjusted Performance
2.0E-4
(0.04)
(0.06)
0.0239
0.0839
(0.02)
0.0108
0.1585
0.1628
(0.07)
Skewness
(1.60)
0.3681
2.55
0.2269
0.2634
0.239
1.08
0.6035
0.9256
(0.36)
Semi Deviation
N/A
N/A
N/A
2.12
1.18
N/A
1.5
1.39
1.96
N/A
Information Ratio
(0.03)
(0.09)
(0.1)
(0)
0.068
(0.04)
(0.03)
0.1815
0.1932
(0.13)
Value At Risk
(4.16)
(4.37)
(8.96)
(4.14)
(2.01)
(15.33)
(1.61)
(2.73)
(3.40)
(5.57)
Expected Short fall
N/A
N/A
N/A
(1.79)
(1.26)
N/A
(1.14)
(1.98)
(2.17)
N/A
Downside Deviation
N/A
N/A
N/A
2.29
1.43
N/A
1.76
1.77
2.75
N/A
Semi Variance
N/A
N/A
N/A
4.52
1.4
N/A
2.26
1.94
3.82
N/A

Nu Skin Competition Performance Charts

Five steps to successful analysis of Nu Skin Competition

Nu Skin's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Nu Skin Enterprises in relation to its competition. Nu Skin's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Nu Skin in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Nu Skin's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Nu Skin Enterprises, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Nu Skin position

In addition to having Nu Skin in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Millennials Best Thematic Idea Now

Millennials Best
Millennials Best Theme
Companies or funds that provide products or services that appeal to the generation of millennials and that are expected to experience growth in the next 5 years. The millennial generation usually refers to the demographic population that were born between 1980 to 2000. The Millennials Best theme has 50 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Millennials Best Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for NUS Stock Analysis

When running Nu Skin's price analysis, check to measure Nu Skin's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nu Skin is operating at the current time. Most of Nu Skin's value examination focuses on studying past and present price action to predict the probability of Nu Skin's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nu Skin's price. Additionally, you may evaluate how the addition of Nu Skin to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY